USPTO serial 79975699
SPYBIOTECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 5, 2023
- Examiner
- CLARK, ANDREW T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SPYBIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, biopharmaceutical and medicinal preparations and substances for the treatment of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; vaccines; vaccine preparations; all of the foregoing for exclusive use in the vaccine and viral based therapeutics field | ACTIVE | — |
| 042 | Medical and pharmaceutical research services; biological research; development of pharmaceutical preparations and medicines; research and development relating to biologics and vaccines; providing medical and scientific research information in the field of pharmaceuticals and vaccines; scientific research in the nature of conducting clinical trials for others in the vaccine and viral based therapeutics field; scientific and medical research consulting services in the nature of clinical trial design for vaccines for others; providing a bioinformatics platform for use in manufacturing therapeutics in the nature of platform as a service (PAAS) featuring computer software for medical data analysis; scientific services relating to the discovery, preclinical and clinical development of vaccines and therapeutic products in the nature of development of pharmaceutical preparations and medicines; research and development of new products for others; development of pharmaceutical products for others; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SPYBIOTECH LIMITED
- Other trademarks owned by SPYBIOTECH LIMITED
- Other trademarks owned by SPYBIOTECH LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SPYBIOTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 7, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 7, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 5, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 5, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 5, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 20, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 20, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 19, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 31, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 31, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 31, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 17, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2023 | MNDA | NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED | — |
| Apr 12, 2023 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 12, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 4, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 15, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 15, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 13, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 27, 2023 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Feb 27, 2023 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 13, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 13, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 13, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 21, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 21, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 28, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 28, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 15, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2022 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jun 7, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 6, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 20, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 14, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |